SALMON EVOLUTION ASA (SALME.OL) Fundamental Analysis & Valuation

OSL:SALME • NO0010892094

4.41 NOK
+0.01 (+0.23%)
Last: Mar 11, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This SALME.OL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to SALME. SALME was compared to 64 industry peers in the Food Products industry. Both the profitability and financial health of SALME have multiple concerns. SALME is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. SALME.OL Profitability Analysis

1.1 Basic Checks

  • SALME had negative earnings in the past year.
  • SALME had a negative operating cash flow in the past year.
  • SALME had negative earnings in each of the past 5 years.
  • SALME had negative operating cash flow in 4 of the past 5 years.
SALME.OL Yearly Net Income VS EBIT VS OCF VS FCFSALME.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 -200M -400M -600M -800M -1B

1.2 Ratios

  • SALME's Return On Assets of -4.02% is on the low side compared to the rest of the industry. SALME is outperformed by 81.25% of its industry peers.
  • SALME's Return On Equity of -8.21% is on the low side compared to the rest of the industry. SALME is outperformed by 79.69% of its industry peers.
Industry RankSector Rank
ROA -4.02%
ROE -8.21%
ROIC N/A
ROA(3y)-3.65%
ROA(5y)-2.78%
ROE(3y)-6.01%
ROE(5y)-4.43%
ROIC(3y)N/A
ROIC(5y)N/A
SALME.OL Yearly ROA, ROE, ROICSALME.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800

1.3 Margins

  • Looking at the Gross Margin, with a value of 51.01%, SALME belongs to the top of the industry, outperforming 89.06% of the companies in the same industry.
  • In the last couple of years the Gross Margin of SALME has declined.
  • SALME does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 51.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.73%
GM growth 5YN/A
SALME.OL Yearly Profit, Operating, Gross MarginsSALME.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. SALME.OL Health Analysis

2.1 Basic Checks

  • SALME does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • SALME has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, SALME has more shares outstanding
  • The debt/assets ratio for SALME is higher compared to a year ago.
SALME.OL Yearly Shares OutstandingSALME.OL Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
SALME.OL Yearly Total Debt VS Total AssetsSALME.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • Based on the Altman-Z score of 0.37, we must say that SALME is in the distress zone and has some risk of bankruptcy.
  • SALME has a worse Altman-Z score (0.37) than 79.69% of its industry peers.
  • SALME has a Debt/Equity ratio of 0.76. This is a neutral value indicating SALME is somewhat dependend on debt financing.
  • SALME has a Debt to Equity ratio of 0.76. This is in the lower half of the industry: SALME underperforms 68.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF N/A
Altman-Z 0.37
ROIC/WACCN/A
WACC7.34%
SALME.OL Yearly LT Debt VS Equity VS FCFSALME.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B

2.3 Liquidity

  • A Current Ratio of 0.84 indicates that SALME may have some problems paying its short term obligations.
  • SALME has a Current ratio of 0.84. This is amonst the worse of the industry: SALME underperforms 81.25% of its industry peers.
  • A Quick Ratio of 0.41 indicates that SALME may have some problems paying its short term obligations.
  • SALME has a Quick ratio of 0.41. This is in the lower half of the industry: SALME underperforms 79.69% of its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.41
SALME.OL Yearly Current Assets VS Current LiabilitesSALME.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. SALME.OL Growth Analysis

3.1 Past

  • SALME shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -236.36%.
  • Looking at the last year, SALME shows a very negative growth in Revenue. The Revenue has decreased by -30.46% in the last year.
  • The Revenue has been growing by 91.79% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-236.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)-30.46%
Revenue growth 3Y91.79%
Revenue growth 5YN/A
Sales Q2Q%-33.59%

3.2 Future

  • Based on estimates for the next years, SALME will show a very strong growth in Earnings Per Share. The EPS will grow by 56.51% on average per year.
  • SALME is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 58.26% yearly.
EPS Next Y57.25%
EPS Next 2Y52.02%
EPS Next 3Y39.66%
EPS Next 5Y56.51%
Revenue Next Year85.7%
Revenue Next 2Y86%
Revenue Next 3Y68.86%
Revenue Next 5Y58.26%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
SALME.OL Yearly Revenue VS EstimatesSALME.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
SALME.OL Yearly EPS VS EstimatesSALME.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2

More info and screens

Find the best growth stocksShow best growing peers

1

4. SALME.OL Valuation Analysis

4.1 Price/Earnings Ratio

  • SALME reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SALME. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SALME.OL Price Earnings VS Forward Price EarningsSALME.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SALME.OL Per share dataSALME.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

  • SALME's earnings are expected to grow with 39.66% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y52.02%
EPS Next 3Y39.66%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SALME.OL Dividend Analysis

5.1 Amount

  • No dividends for SALME!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SALME.OL Fundamentals: All Metrics, Ratios and Statistics

SALMON EVOLUTION ASA

OSL:SALME (3/11/2026, 7:00:00 PM)

4.41

+0.01 (+0.23%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)02-24
Earnings (Next)05-12
Inst Owners22.72%
Inst Owner ChangeN/A
Ins Owners2.16%
Ins Owner ChangeN/A
Market Cap2.04B
Revenue(TTM)325.25M
Net Income(TTM)-169.31M
Analysts86.25
Price Target7.77 (76.19%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)55.87%
Min EPS beat(2)11.74%
Max EPS beat(2)100%
EPS beat(4)2
Avg EPS beat(4)-79.84%
Min EPS beat(4)-220.42%
Max EPS beat(4)100%
EPS beat(8)4
Avg EPS beat(8)-195.85%
EPS beat(12)5
Avg EPS beat(12)-149.38%
EPS beat(16)9
Avg EPS beat(16)-101.06%
Revenue beat(2)0
Avg Revenue beat(2)-10.88%
Min Revenue beat(2)-18.01%
Max Revenue beat(2)-3.75%
Revenue beat(4)0
Avg Revenue beat(4)-20.63%
Min Revenue beat(4)-43.93%
Max Revenue beat(4)-3.75%
Revenue beat(8)2
Avg Revenue beat(8)-15.15%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.74%
EPS NQ rev (1m)-98.35%
EPS NQ rev (3m)-98.35%
EPS NY rev (1m)-27.97%
EPS NY rev (3m)-185.71%
Revenue NQ rev (1m)-3.13%
Revenue NQ rev (3m)-3.13%
Revenue NY rev (1m)-2.35%
Revenue NY rev (3m)-5.92%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.27
P/FCF N/A
P/OCF N/A
P/B 0.99
P/tB 1.03
EV/EBITDA N/A
EPS(TTM)-0.37
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)-2.86
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS0.7
BVpS4.46
TBVpS4.28
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.02%
ROE -8.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 51.01%
FCFM N/A
ROA(3y)-3.65%
ROA(5y)-2.78%
ROE(3y)-6.01%
ROE(5y)-4.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.73%
GM growth 5YN/A
F-Score1
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1576.19%
Cap/Sales 388.76%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.41
Altman-Z 0.37
F-Score1
WACC7.34%
ROIC/WACCN/A
Cap/Depr(3y)889.5%
Cap/Depr(5y)10179.9%
Cap/Sales(3y)217.51%
Cap/Sales(5y)1789.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-236.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y57.25%
EPS Next 2Y52.02%
EPS Next 3Y39.66%
EPS Next 5Y56.51%
Revenue 1Y (TTM)-30.46%
Revenue growth 3Y91.79%
Revenue growth 5YN/A
Sales Q2Q%-33.59%
Revenue Next Year85.7%
Revenue Next 2Y86%
Revenue Next 3Y68.86%
Revenue Next 5Y58.26%
EBIT growth 1Y-3261.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year179.28%
EBIT Next 3Y76.48%
EBIT Next 5Y56.25%
FCF growth 1Y-304.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-236.28%
OCF growth 3YN/A
OCF growth 5YN/A

SALMON EVOLUTION ASA / SALME.OL FAQ

What is the fundamental rating for SALME stock?

ChartMill assigns a fundamental rating of 2 / 10 to SALME.OL.


What is the valuation status of SALMON EVOLUTION ASA (SALME.OL) stock?

ChartMill assigns a valuation rating of 1 / 10 to SALMON EVOLUTION ASA (SALME.OL). This can be considered as Overvalued.


Can you provide the profitability details for SALMON EVOLUTION ASA?

SALMON EVOLUTION ASA (SALME.OL) has a profitability rating of 1 / 10.


What is the financial health of SALMON EVOLUTION ASA (SALME.OL) stock?

The financial health rating of SALMON EVOLUTION ASA (SALME.OL) is 0 / 10.


What is the earnings growth outlook for SALMON EVOLUTION ASA?

The Earnings per Share (EPS) of SALMON EVOLUTION ASA (SALME.OL) is expected to grow by 57.25% in the next year.